The Food and Drug Administration (FDA) said it is unable to regulate CBD products under its current structure because the hemp- or marijuana-derived ingredient hasn’t been shown to be safe enough for food or supplements. The FDA called on Congress to create new rules for the massive and growing market for hemp- or marijuana-derived products, which have become increasingly popular in lotions, tinctures and foods and is projected to reach sales of $22 billion by 2030. Meanwhile, the legal status of CBD products has been murky in the U.S. Questions remain about CBD’s effects on the liver, the male reproductive system and on pregnant women and children, the FDA statement said.